Hjem › Type 2-diabetes › New Mexico › Albuquerque
Type 2-diabetes kliniske forsøg i Albuquerque, NM
11 studier for Type 2-diabetes søger deltagere på steder i og omkring Albuquerque (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema
RekruttererFase 3
- Albuquerque Clinical Trials Inc., Albuquerque
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
RekruttererFase 3
- New Mexico Clinical Research and Osteoporosis Center, Inc., Albuquerque
- IMA Clinical Research Albuquerque, Albuquerque
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
RekruttererFase 3
- Albuquerque Clinical Trials, Albuquerque
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
RekruttererFase 3
- Albuquerque Clinical Trials, Inc., Albuquerque
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
RekruttererFase 3
- Albuquerque Clinical Trials, Inc., Albuquerque
A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus
RekruttererFase 2
- Albuquerque Clinical Trials Inc, Albuquerque
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
RekruttererFase 3
- Research Site, Albuquerque
Ketogenic Diet and Diabetes Demonstration Project
RekruttererFrivillige med god helbredstilstand velkomne
- University of New Mexico, Albuquerque
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
RekruttererFase 3
- Research Site, Albuquerque
A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
RekruttererFase 3
- Research Site, Albuquerque
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
RekruttererFase 3
- University of New Mexico Hospital, Albuquerque
Type 2-diabetes forsøg i andre byer
- San Antonio, TX37 studier
- Houston, TX31 studier
- Orlando, FL24 studier
- Boston, MA20 studier
- Miami, FL19 studier
- Chicago, IL19 studier
- Dallas, TX19 studier
- Columbus, OH18 studier
- Las Vegas, NV18 studier
- Atlanta, GA17 studier
- San Diego, CA17 studier
- Los Angeles, CA16 studier
Andre studier i Albuquerque
- Ikke-småcellet lungecancer18 studier
- Brystkræft17 studier
- Ægstockræft15 studier
- Lungecancer14 studier
- Kræft (alle typer)14 studier
- Livmoderslimhindekræft12 studier
- Metastatisk cancer12 studier
- Kardiovaskulær sygdom10 studier
- Prostatakræft9 studier
- Melanom9 studier
- Akut myeloid leukæmi9 studier
- Kronisk nyresygdom8 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.